Brief: XBiotech Announces Medical Research Council Funding
09/07/2019 13:49
July 9 (Reuters) - XBiotech Inc XBIT.O :
* MEDICAL RESEARCH COUNCIL FUNDS PHASE 2 MULTI-CENTER STUDY
OF
XBIOTECH’S BERMEKIMAB IN ADVANCED CANCER PATIENTS
Source text for Eikon: ID:nGNE84Vlyv
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke